Zu-Jiang Yu

Publications59
h-index12
Citations607
Highly Influential Citations21
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Buti
  • 805 Publications • 28,534 Citations
  • Q. Zeng
  • 55 Publications • 571 Citations
  • F. Zoulim
  • 787 Publications • 36,794 Citations
  • N. Terrault
  • 622 Publications • 29,582 Citations
  • Publications
  • Influence
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients
TLDR
Convalescent plasma treatment can discontinue SARS-CoV-2 shedding but cannot reduce mortality in critically end-stage COVID-19 patients, and treatment should be initiated earlier.
Unexpected high incidence of hepatocellular carcinoma in patients with hepatitis C in the era of DAAs: Too alarming?
LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
AMPK activation ameliorates D‐GalN/LPS‐induced acute liver failure by upregulating Foxo3A to induce autophagy
MiR‐19a Affects Hepatocyte Autophagy via Regulating lncRNA NBR2 and AMPK/PPARα in D‐GalN/Lipopolysaccharide‐Stimulated Hepatocytes
TLDR
It is suggested that miR‐19a negatively controlled the autophagy of hepatocytes attenuated in D‐GalN/LPS‐stimulated hepatocytes via regulating NBR2 and AMPK/PPARα signaling.
Hyperammonaemia induces hepatic injury with alteration of gene expression profiles
TLDR
It is unknown whether hyperammonaemia has a direct adverse effect on the hepatocytes and thereby serves as both a cause and effect of hepatic failure.
Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study.
The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors.
Clinical course and treatment efficacy of COVID‐19 near Hubei Province, China: a multicentre, retrospective study
TLDR
The viral shedding duration and clinical course in Henan and Shaanxi Provinces were shorter than those in Hubei Province, and current antiviral therapies were ineffective for shortening viral sheddingurations and clinical courses in real‐world settings.
Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
TLDR
Antiviral prophylaxis with TAF was determined to be generally safe for both mothers and infants and reduced the MTCT rate to 0%.
...
1
2
3
4
5
...